Back to News
Market Impact: 0.32

Pro-Dex Jumps On Higher Q4 Earnings And Revenue Growth

Source: Nasdaq

Company FundamentalsCorporate EarningsAnalyst Insights

Pro-Dex (PDEX) reported Q4 revenue growth of 17% and full-year revenue growth of 16% for the year ended June 30, 2026. The results indicate solid top-line momentum for the developer and manufacturer of powered surgical instruments. Overall, the update is supportive but limited in detail, suggesting potential for modest single-stock movement.

AllMind Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Trial

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.25

Ticker Sentiment

PDEX0.35

More News

From AllMind Research

Browse all research